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Sunday, February 8, 2015 65alipid bilayer interactions. To understand Ab-lipid interactions at molecular
level, we have performed all-atom explicit solvent replica exchange molecular
dynamics simulations in the isobaric-isothermal ensemble of the Ab monomer
binding to the zwitterionic DMPC bilayer. Upon binding, Ab undergoes a dra-
matic structural transition from random coil state in water to a state predomi-
nated by stable helical structure in the peptide’s hydrophobic C-terminal and,
to a lesser extent, the central hydrophobic cluster. In addition, binding to the lipid
bilayer induces the formation of the intrapeptide Asp23-Lys28 salt bridge. The
peptide’s C-terminal and central hydrophobic cluster do not only govern binding
to the bilayer but they also penetrate into the bilayer core. In contrast, the polar
N-terminal and turn region remain solvated and mainly form interactions with
the bilayer surface. This partial insertion of Ab reduces the local density of lipids
and creates an indentation in the bilayer. Surprisingly, peptide insertion does not
significantly distort lipid structural properties or enhance water permeation.
Taken together, these results suggest that Ab aggregation in the presence of a
zwitterionic lipid bilayer is likely to be different from that in bulk water. Small
structural perturbations in lipids induced by the Abmonomer may constitute the
molecular basis of its low cytotoxicity.
326-Pos Board B106
Amyloid-b Oligomers: Now for the Structure in the Membrane
Debanjan Bhowmik1, Sudipta Maiti1, Kaustubh Mote2,
Bappaditya Chandra1, Perunthiruthy Madhu1.
1Department of Chemical sciences, Tata Institute of Fundamental Research,
Mumbai, India, 2TCIS, Tata Institute of Fundamental Research, Hyderabad,
India.
Small oligomers of Amyloid-b (Ab), rather than the mature fibrils, are sus-
pected to initiate Alzheimer’s disease (AD). The structures of these oligomers
in the solution, and in the membrane phase, are expected to provide significant
cues for addressing their toxicity. However, it is difficult to determine the struc-
ture of these peptides as they are transient, and only exist at low mM concen-
trations. We recently combined rapid fluorescence techniques with slower
two-dimensional solid state NMR to obtain useful atomic-level information
on their structure in the solution phase1,2. However, though membrane interac-
tion is a necessary step for this extra-cellular peptide to be toxic3, their structure
in the membrane phase remains elusive. We have developed a modified Surface
Enhanced Raman Spectroscopy method which is able to probe the structure of
membrane proteins at individual residue levels. Using this technique, we deter-
mine the region-wise structure of the membrane-active oligomers, and compare
these with those determined by solid state NMR spectroscopy. We show that
there are critical differences in the structure of the oligomers and the fibrils,
even though they share the same gross molecular architecture. These differ-
ences may be the key to understanding.
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The deposition of amyloid b (Ab) peptides is a pathological hallmark of
Alzheimer’s disease. Ab peptides were previously considered to interact specif-
ically with ganglioside-containing membranes. However, several studies have
suggested that Ab peptides also bind to phosphatidylcholine (PC) membranes,
which lead to deformation of membranes and fibrillation of Ab. Moreover, the
role of membrane curvature, one type of deformation produced by binding of
proteins to a membrane, in the binding and fibrillation of Ab remains unclear.
To more clearly understand the relationship between the binding, consequent
membrane deformation and fibrillation of Ab, we examined the amyloid fibril-
lation of Ab (1-40) in the presence of liposomes of various sizes. Membrane
curvature increased with a decrease in the size of the liposomes. We used lipo-
somes made of 1,2-dioleoyl-sn-glycero-3- phosphocholine to eliminate electro-
static effects. The results obtained showed that liposomes of smaller sizes
(% 50 nm) significantly accelerated the nucleation step, thereby shortening
the lag time of fibrillation. On the other hand, liposomes of larger sizes
decreased the amount of fibrils, but did not notably affect the lag time. The mor-
phologies of fibrils, which were monitored by total internal reflection fluores-
cence microscopy, atomic force microscopy, and transmission electronmicroscopy, revealed that the length of Ab (1-40) fibrils became shorter and
the amount of amorphous aggregates became larger as liposomes increased
in size. These results suggest that the curvature of membranes coupled with
an increase in water-accessible hydrophobic regions is important for binding
and concentrating Ab monomers, leading to amyloid nucleation. Furthermore,
amyloid fibrillation on membranes may compete with non-productive binding
to produce amorphous aggregates.
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Ab is 40-residue peptide, unstructured and present in all brain tissue. In Alz-
heimer’s disease, Ab peptides spontaneously aggregate and form fibrils. Fibril
formation begins with a nucleation step that is poorly understood. Factors that
cause nucleation are likely to be related with the cause of Alzheimer’s disease.
To understand the nucleation step, while preventing protein aggregation into
fibrils, we have encapsulated Ab peptides in reverse micelles (RMs) -
nanometer-sized droplets of water, surrounded by a surfactant, immersed in
an organic solvent. In addition to preventing aggregation, RMs may mimic
aspects of the in vivo circumstances where Ab peptides form fibrils, such as
molecular crowding, confinement, and high ionic strength. MD simulations
were performed to better understandRMproperties, and the behavior of Ab pep-
tides in an RM. This computational study provides a detailed molecular model
for an AOTRM.Our results show that 64 AOTmolecules and aWo¼ 7.5 yields
an RMwith dimensions that are consistent with experimental data. WhenWo¼
7.5 and the number of AOTmolecules is greater than 64, the RM shape becomes
markedly non-spherical and begins to split. When Wo ¼ 7.5 and the number of
AOT molecules is less than 64, the resulting RM has an insufficient number of
AOT molecules to separate water from isooctane. Even with 64 AOT per RM,
there is an overlap of water and isooctane phases that facilitates both the escape
ofwaters from theRMcore, and their re-entry. These processes - observable now
in a detailed simulation - account for the narrow size distribution of RM at equi-
librium. When incorporated in an RM, Ab peptides may locate in the surfactant
layer and increase RM surface area as well as volume.
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Alzheimer’s disease (AD) is a fatal neurodegenerative disorder that is the most
common cause of dementia. The self-assembly of the b-amyloid peptide (Ab)
into ordered aggregates, including oligomers and fibrils, is a major hallmark of
AD. As we age, significant alterations in our cellular structure, with implica-
tions for cellular mechanics, occur. An example of such changes are alterations
in the structure of microtubules within cells. As aging is the largest risk factor
for the development of AD, we investigated the role of microtubule structure on
a cell’s ability to cope with exposure to Ab. Microtubules in GT1-7 cells were
systematically altered using a variety of microtubule-altering drugs. Nocoda-
zole and cholchicine were used to disrupt microtubules; paclitaxel was used
to stabilize microtubules. The effectiveness of the drugs to change microtubule
structure was confirmed by fluorescence microscopy and mechanical measure-
ments using an atomic force microscope. Control cells and cells with altered
microtubule structure were then exposed to monomeric and oligomeric solu-
tions of Ab, as confirmed by several assays. Next, we determined the extent
of Ab binding to cells using flow cytometry, cell death using a variety of
toxicity assays, and Ab-induced changes in cell mechanical properties. We
found that altering microtubule structure had little effect on the ability of Ab
to bind cells. However, Ab-related toxicity was enhanced when cells had dis-
rupted microtubule networks, indicating that they were more sensitive to expo-
sure to Ab. Cells that had their microtubule networks chemically stabilized
were more resistant to Ab-related toxicity.
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Protein aggregation is a complex, multistep process, but the first step is likely the
formation of a dimer through non-specific interactions of two disordered mono-
mers. In this work we measure the rate of reconfiguration, or intramolecular
diffusion, of monomeric Abeta peptides and find a correlation between this
rate and the aggregation rate. Using the method of Trp-Cys contact quenching
we find that the rate of reconfiguration is ~5 times faster for Abeta40, which
